Christopher J. Hasenberg’s Pfizer PFE Stock Holding History

Christopher J. Hasenberg’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$7.32K	Hold	302	–	–	﹤0.01%	157
2025 Q1	$7.41K	Hold	302	–	–	﹤0.01%	131
2024 Q4	$8.01K	Hold	302	–	–	﹤0.01%	121
2024 Q3	$8.81K	Buy	302 +160	+113%	+$4.67K	﹤0.01%	116
2024 Q2	$3.97K	Hold	142	–	–	﹤0.01%	105
2024 Q1	$3.94K	Buy	+142	New	+$3.94K	﹤0.01%	87

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Christopher J. Hasenberg's PFE Position: Q2 2025 in Review

Christopher J. Hasenberg held its Pfizer (PFE) position steady in Q2 2025 at 302 shares worth $7.32K. The position accounts for ﹤0.01% of the portfolio, ranked #157.

Christopher J. Hasenberg first reported a position in PFE in Q1 2024 and has held it in 6 quarters since. The position peaked at $8.81K in Q3 2024. 2,810 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

Christopher J. Hasenberg held 302 shares of Pfizer worth $7.32K as of Q2 2025.
Christopher J. Hasenberg left its Pfizer share count unchanged in Q2 2025.
Pfizer made up ﹤0.01% of Christopher J. Hasenberg's portfolio in Q2 2025, its #157 holding.
Christopher J. Hasenberg first reported a position in Pfizer in Q1 2024 and has held it in 6 quarters since.
Christopher J. Hasenberg's Pfizer position peaked at $8.81K in Q3 2024.
2,810 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Christopher J. Hasenberg's 13F filing for Q2 2025, filed 9 Jul 2025.